MedCity News November 20, 2024
Stephanie Baum

Personify Health Chief Medical Officer Jeff Jacques offers a window into companies’ strategies for including GLP-1 drugs in their health benefits.

At a time when self-insured employers are searching for ways to address escalating healthcare costs, the rise of GLP-1 drugs for weight loss poses some interesting questions for employers. Could investment in these pricey drugs as a health benefit stem the cost of chronic conditions in the long term? How do employers decide who should get access to these...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Conferences / Podcast, Insurance, Pharma / Biotech, Self-insured, Trends
Elevance Health Bolsters Employer Insurance Business
Accolade Gets a Do-Over With Transcarent’s $621M Acquisition
Transcarent to buy Accolade for $621M
Transcarent to acquire fellow health benefits navigator Accolade for $621M
Transcarent To Acquire Accolade

Share This Article